PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
10-May-2022 Ashfield Engage acquires ‘smart data’ organization PROPENSITY4 Ashfield Engage
10-May-2022 Registration is now open for Oligonucleotide Therapeutics and Delivery Conference SAE Media Group
10-May-2022 Kaiku Health enters a strategic partnership to further improve patient outcomes through digital patient monitoring Kaiku Health
10-May-2022 NHS Scotland first in the UK to approve JYSELECA®▼ (filgotinib) for a form of Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) Galapagos UK
10-May-2022 Cegedim Healthcare Solutions leads discussion on pragmatic approaches to Population Health Management at this year’s Digital Healthcare Show Cegedim Healthcare Solutions
09-May-2022 Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey mdgroup
09-May-2022 Scottish Medicines Consortium Accepts Chemotherapy-free Combination Treatment VENCLYXTO®▼(Venetoclax) Plus Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia AbbVie
09-May-2022 Journal of Bone and Joint Surgery Publishes Recommendations to Establish Best Practice for Venous Thromboembolism (VTE) Prophylaxis in Orthopedics Cardinal Health
06-May-2022 How MRI could revolutionise heart failure diagnosis University of East Anglia
05-May-2022 New EFSA opinion offers future FSMP application potential for Bimuno® prebiotic ingredient Clasado Biosciences
05-May-2022 Medicago announces publication of Phase 3 COVID-19 vaccine study results in New England Journal of Medicine Medicago
04-May-2022 Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger Phesi
04-May-2022 BD sponsors Isla Care’s creation of an AI-powered solution to help tackle the complex challenge of post-surgery wound assessment BD
04-May-2022 Foundation S: Sanofi’s new philanthropic spearhead Sanofi
03-May-2022 Hearables’ Shipments to Exceed 200 Million Globally by 2024, as Vendors Embrace Innovative Use Cases Juniper Research
03-May-2022 miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test miDiagnostics
03-May-2022 Europe’s first dual orexin receptor antagonist – QUVIVIQ (daridorexant) – granted approval to improve both nighttime symptoms and daytime functioning in adults with chronic insomnia disorder Idorsia
29-Apr-2022 Insulin glargine 300U/ml for people with Type 1 diabetes meets primary endpoint in InRange head-to-head study versus insulin degludec Sanofi
28-Apr-2022 Strathclyde joins global network dedicated to accelerated breakthroughs in human health University of Strathclyde
28-Apr-2022 Evaluate report signals orphan drug market is niche no more Evaluate